EHP-101, an experimental treatment being clinically tested for multiple sclerosis (MS), activates a cellular signaling pathway that promotes blood…
Articles by Marisa Wexler, MS
A new tool that analyzes gait, or walking patterns, of people on a treadmill — using video recordings from a…
NexImmune is working with the National Institute of Neurological Disorders and Stroke (NINDS) to develop cell therapies for…
Data passively collected by smartphone apps and fitness trackers can be used to accurately predict the risk of depression, severe…
Among children and adolescents with multiple sclerosis (MS), treatment with Tecfidera (dimethyl fumarate) resulted in less disease activity…
A novel tracer designed to detect myelin loss in PET scans — imaging tests that use a radioactive substance, called…
Electrical stimulation of the brain through electrodes placed on the scalp may ease some measures of spasticity for people with…
Autologous hematopoietic stem cell transplant (aHSCT) reduces markers of nerve fiber and myelin damage in people with relapsing-remitting…
Guar gum, a type of dietary fiber that can be taken as a supplement, lessened inflammation and disease severity in…
A quick MRI-based method called SyMRI may be useful in future clinical trials to test experimental myelin-repairing therapies in diseases…
The Overall Disability Response Score, a combination of three different assessments of disability, could be used to more accurately evaluate…
A new machine learning tool could help make clinical trials for progressive forms of multiple sclerosis (MS) more efficient…
Even in early stages of disease, people with multiple sclerosis (MS) commonly experience more difficulties performing cognitive and motor…
The rates of pregnancy complications are not higher in women with multiple sclerosis (MS) who were using disease-modifying therapies…
The likelihood of survival is about 7.5 times higher for people with multiple sclerosis (MS) who take their disease-modifying…
A robot-assisted training program that uses game-like activities to improve upper limb function was met with high satisfaction and enjoyment…
Treatment with GA Depot, an experimental long-acting form of glatiramer acetate that requires less frequent dosing than approved formulations,…
In people with multiple sclerosis (MS) who show atrophy in a brain region called the thalamus, aerobic fitness is…
The composition of bacteria in the gut is altered in multiple sclerosis (MS) patients compared with healthy people in…
NurOwn, a stem cell therapy being developed by BrainStorm Cell Therapeutics, showed a good safety profile among people with progressive…
The approved dosage of the multiple sclerosis (MS) therapy Ponvory (ponesimod) — 20 mg taken by mouth once…
People with multiple sclerosis (MS) have significantly more T-cells equipped with receptors that specifically recognize the Epstein-Barr virus (EBV)…
In multiple sclerosis (MS), disease-causing immune T-cells enter the brain and spinal cord through the protective soft membranes covering…
Long-term treatment with Tysabri (natalizumab) significantly improves cognitive function and increases the chance of disability reduction in people with…
People with relapsing multiple sclerosis (MS) treated with Tysabri (natalizumab) or Gilenya (fingolimod) are less likely to…
People with secondary progressive multiple sclerosis (SPMS) have more microscopic damage in normal-appearing brain tissue than do patients with…
Abnormalities in the auditory and vestibular systems, which control hearing and balance, are frequently reported among people with multiple…
Treatment with medrysone, a glucocorticoid approved in the U.S. as a topical treatment for certain inflammatory eye diseases, improved…
The protective barrier that prevents cells and large molecules from crossing into the central nervous system (CNS) is known to…
Treatment with the experimental B-cell depleting therapy ublituximab significantly outperformed Aubagio (teriflunomide) at reducing relapse rates and the…